Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Biomedical Materials (Bristol, England)|January 16, 2018
Ligand-cascading nano-delivery devices to enable multiscale targeting of anti-neurodegenerative therapeuticsAdam S Mullis, Benjamin W Schlichtmann, Balaji Narasimhan, et al.Current Opinion in Chemical Engineering|April 14, 2022
NANOTECHNOLOGY-MEDIATED THERAPEUTIC STRATEGIES AGAINST SYNUCLEINOPATHIES IN NEURODEGENERATIVE DISEASEBenjamin W Schlichtmann, Monica Hepker, Bharathi N Palanisamy, et al.Journal of Biomedical Materials Research. Part B, Applied Biomaterials|July 27, 2021
Functionalized polyanhydride nanoparticles for improved treatment of mitochondrial dysfunctionBenjamin W Schlichtmann, Balaraman Kalyanaraman, Rainie L Schlichtmann, et al.ACS Chemical Neuroscience|November 16, 2020
Enzyme Immunoassay-Based Platform for Accurate Detection of Serum Pathological α-Synuclein in Parkinson's Disease PatientsBenjamin W Schlichtmann, Naveen Kondru, Monica M Hepker, et al.Biomolecules|August 26, 2023
Aggregation-Inhibiting scFv-Based Therapies Protect Mice against AAV1/2-Induced A53T-α-Synuclein OverexpressionBenjamin W Schlichtmann, Bharathi N Palanisamy, Emir Malovic, et al.Nature Communications|May 23, 2017
Shifting the optimal stiffness for cell migrationBenjamin L Bangasser, Ghaidan A Shamsan, Clarence E Chan, et al.Journal of Biomedical Materials Research. Part A|October 29, 2018
Biodegradable polyanhydride-based nanomedicines for blood to brain drug deliveryTimothy M Brenza, Benjamin W Schlichtmann, Biju Bhargavan, et al.Pageof 1